US misses the mark in Southeast Asia with strategy to blame China
The US’s campaign to strengthen its influence in Southeast Asia — part of its escalating global rivalry with China — has been misfiring
27 October 2020 - 13:46
Jakarta — For months, by Zoom calls and then by jet, Indonesian ministers and officials scoured the world for access to a vaccine for the coronavirus that Southeast Asia’s biggest country is struggling to control. In October, their campaign paid off.
Three Chinese companies committed 250-million doses of vaccines to the archipelago of 270-million people. A letter of intent was signed with a UK-based company for another 100-million...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.